China has done well in infection control since the early part of the COVID-19 pandemic. Apart from the strict, rather drastic measures of isolation, containment, and restrictions, there is a general belief that the integrative use of Traditional Chinese Medicine has helped to give better treatment outcomes.
The use of integrated treatment has been endorsed and guided on a national level and supported by the general public. Experts recommended specific choices of herbal formulae to be used at different stages of infection -- mild, moderate, and severe.
Historical accounts on the clinical effectiveness of herbal medicine to infections are plentiful in China, particularly for respiratory infections. In the past decades, many widespread influenza epidemics in China have involved extensive uses of Traditional Chinese Medicine with many apparent merits. For example, the recent SARS crisis of 2003 saw 60 per cent of infected patients in China receiving Chinese Medicine treatment. Subsequent analysis of the clinical value revealed the remarkable efficacies of its supportive role on fever, cough, and other symptomatic control.